Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunity to Influenza Infection in Humans
David J. Topham, Marta L. DeDiego, Aitor Nogales, et al.
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 11, Iss. 3, pp. a038729-a038729
Open Access | Times Cited: 12

Showing 12 citing articles:

COVID-19 in Colombia endpoints. Are we different, like Europe?
Pedro Amariles, Johan Granados, Mauricio Ceballos, et al.
Research in Social and Administrative Pharmacy (2020) Vol. 17, Iss. 1, pp. 2036-2039
Open Access | Times Cited: 58
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
Kristine A. Moore, Julie Ostrowsky, Alison M. Kraigsley, et al.
Vaccine (2021) Vol. 39, Iss. 45, pp. 6573-6584
Open Access | Times Cited: 52
Immune-mediated attenuation of influenza illness after infection: opportunities and challenges
Manish M. Patel, Ian A. York, Arnold S. Monto, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 12, pp. e715-e725
Open Access | Times Cited: 42
Next-Generation Influenza Vaccines
Masaru Kanekiyo, Barney S. Graham
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 8, pp. a038448-a038448
Open Access | Times Cited: 29
Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems
Chantelle L. White, Maryah A. Glover, Siva K. Gandhapudi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 281-281
Open Access | Times Cited: 2
Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
Aitor Nogales, Marta L. DeDiego, Luis Martínez‐Sobrido
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines
Sang‐Hyun Kim, Erica Españo, Bill Thaddeus Padasas, et al.
Immune Network (2024) Vol. 24, Iss. 3
Open Access | Times Cited: 1
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
Aitor Nogales, John Steel, Wen‐Chun Liu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 6
The Immune Response to Respiratory Viruses: From Start to Memory
Tom D. Y. Reijnders, Alex R. Schuurman, Tom van der Poll
Seminars in Respiratory and Critical Care Medicine (2021) Vol. 42, Iss. 06, pp. 759-770
Closed Access | Times Cited: 7
Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
Aitor Nogales, Michael Schotsaert, Raveen Rathnasinghe, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 698-698
Open Access | Times Cited: 5
A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccine
Aitor Nogales, John Steel, Wen‐Chun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
INNOVATIONS IN MODERN MEDICINE AND BIOLOGY
Denis Vladlenov, Anastasiya Chepurna, Andrii Korz, et al.
(2022)
Open Access
Page 1

Scroll to top